Tapewire

NYSE · USD

CI

Cigna Group

Export transactions ↓
Tapewire entity
550
SEC CIK
0001739940
Parsed reports
653

Last 12 months

Inside the activity.

1 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 2026013
Jun 202601
Jul 202600
Aug 202602
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 03, 2026 Filed Sep 8, 2026 20:29 UTC
Neville EverettSee Remarks
SaleCommon Stock, $.01 Par Value 617 $284.05 $175,258.85
Disclosure

SEC source: 0001641142-26-000003 · wk-form4_1788899344.xml · nonDerivative · entry 1

Neville Everett · CIK 0001641142 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,053

F1 · acquired: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2026.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:21 UTC
Evanko Brian CSee Remarks
GrantEmployee Stock Option (Right to Buy) · Derivative 6,716 $0.00 Strike: $281.13 $0.00
Disclosure

SEC source: 0001722909-26-000007 · wk-form4_1788466902.xml · derivative · entry 4

Evanko Brian C · CIK 0001722909 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,716

Underlying: Common Stock, $0.01 Par Value · 6,716 shares

Expires 2037-09-01

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning September 1, 2027.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:21 UTC
Evanko Brian CSee Remarks
GrantCommon Stock, $.01 Par Value 3,113 $0.00 $0.00
Disclosure

SEC source: 0001722909-26-000007 · wk-form4_1788466902.xml · nonDerivative · entry 1

Evanko Brian C · CIK 0001722909 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,030

F1 · shares: These restricted shares vest in three equal annual installments beginning September 1, 2027.

Read SEC document
August 31, 2026 Filed Sep 2, 2026 20:23 UTC GrantPhantom Stock Units · Derivative 108.6642 $276.08 $30,000.01
Disclosure

SEC source: 0001586813-26-000006 · wk-form4_1788380624.xml · derivative · entry 1

Kurian George · CIK 0001586813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,041.8523

Underlying: Common Stock, $.01 Par Value · 108.6642 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F2 · ownership.direct: Includes 10.7387 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.

Read SEC document
August 18, 2026 Filed Aug 20, 2026 21:07 UTC
Jones Nicole SSee Remarks
SaleCommon Stock, $.01 Par Value 2,677 $279.61 $748,515.97
Disclosure

SEC source: 0001492663-26-000003 · wk-form4_1787260034.xml · nonDerivative · entry 1

Jones Nicole S · CIK 0001492663 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,880

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026.

Read SEC document
August 06, 2026 Filed Aug 20, 2026 21:13 UTC
Holgerson BryanSee Remarks
GrantPhantom Stock Units · Derivative 0.9837 $275.25 $270.76
Disclosure

SEC source: 0002142615-26-000003 · wk-form4_1787260436.xml · derivative · entry 4

Holgerson Bryan · CIK 0002142615 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 944.6253

Underlying: Common Stock, $.01 Par Value · 0.9837 shares

Expires not disclosed

F2 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund.

F2 · derivative.exercise_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund.

F2 · derivative.expiration_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund.

Read SEC document
August 05, 2026 Filed Aug 6, 2026 20:31 UTC
Jones Nicole SSee Remarks
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,301 $0.00 Strike: $192.02 $0.00
Disclosure

SEC source: 0001739940-26-000067 · wk-form4_1786048270.xml · derivative · entry 6

Jones Nicole S · CIK 0001492663 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 Par Value · 1,301 shares

Expires 2030-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026.

F3 · derivative.exercise_date: This option was granted on February 26, 2020. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Read SEC document
August 05, 2026 Filed Aug 6, 2026 20:31 UTC
Jones Nicole SSee Remarks
Exercise / conversionCommon Stock, $.01 Par Value 1,301 $192.02 $249,818.02
Disclosure

SEC source: 0001739940-26-000067 · wk-form4_1786048270.xml · nonDerivative · entry 3

Jones Nicole S · CIK 0001492663 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,557

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026.

Read SEC document
August 04, 2026 Filed Aug 6, 2026 20:31 UTC
Jones Nicole SSee Remarks
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 14,045 $0.00 Strike: $192.02 $0.00
Disclosure

SEC source: 0001739940-26-000067 · wk-form4_1786048270.xml · derivative · entry 5

Jones Nicole S · CIK 0001492663 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,301

Underlying: Common Stock, $.01 Par Value · 14,045 shares

Expires 2030-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026.

F3 · derivative.exercise_date: This option was granted on February 26, 2020. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Read SEC document
August 04, 2026 Filed Aug 6, 2026 20:31 UTC
Jones Nicole SSee Remarks
SaleCommon Stock, $.01 Par Value 19,436 $276.27 $5,369,583.72
Disclosure

SEC source: 0001739940-26-000067 · wk-form4_1786048270.xml · nonDerivative · entry 2

Jones Nicole S · CIK 0001492663 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,256

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026.

Read SEC document
August 04, 2026 Filed Aug 6, 2026 20:31 UTC
Jones Nicole SSee Remarks
Exercise / conversionCommon Stock, $.01 Par Value 14,045 $192.02 $2,696,920.90
Disclosure

SEC source: 0001739940-26-000067 · wk-form4_1786048270.xml · nonDerivative · entry 1

Jones Nicole S · CIK 0001492663 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,692

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026.

Read SEC document
July 23, 2026 Filed Aug 20, 2026 21:13 UTC
Holgerson BryanSee Remarks
GrantPhantom Stock Units · Derivative 0.9458 $286.29 $270.77
Disclosure

SEC source: 0002142615-26-000003 · wk-form4_1787260436.xml · derivative · entry 3

Holgerson Bryan · CIK 0002142615 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 943.6416

Underlying: Common Stock, $.01 Par Value · 0.9458 shares

Expires not disclosed

F2 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund.

F2 · derivative.exercise_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund.

F2 · derivative.expiration_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund.

Read SEC document
July 09, 2026 Filed Aug 20, 2026 21:13 UTC
Holgerson BryanSee Remarks
GrantPhantom Stock Units · Derivative 0.8873 $291.80 $258.91
Disclosure

SEC source: 0002142615-26-000003 · wk-form4_1787260436.xml · derivative · entry 2

Holgerson Bryan · CIK 0002142615 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 942.6958

Underlying: Common Stock, $.01 Par Value · 0.8873 shares

Expires not disclosed

F2 · derivative.exercise_price: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund.

F2 · derivative.exercise_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund.

F2 · derivative.expiration_date: Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash in accordance with the terms of The Cigna Group Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 21:05 UTC
Kates Jamie GChief Accounting Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 899 $0.00 Strike: $152.89 $0.00
Disclosure

SEC source: 0001739940-26-000047 · wk-form4_1781643916.xml · derivative · entry 3

Kates Jamie G · CIK 0002029677 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 Par Value · 899 shares

Expires 2028-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option was granted on February 28, 2018. The option vested in three equal annual installments starting on February 28, 2019.

Read SEC document
June 12, 2026 Filed Jun 16, 2026 21:05 UTC
Kates Jamie GChief Accounting Officer
SaleCommon Stock, $.01 Par Value 899 $298.61 $268,452.19
Disclosure

SEC source: 0001739940-26-000047 · wk-form4_1781643916.xml · nonDerivative · entry 2

Kates Jamie G · CIK 0002029677 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,368

Read SEC document
June 12, 2026 Filed Jun 16, 2026 21:05 UTC
Kates Jamie GChief Accounting Officer
Exercise / conversionCommon Stock, $.01 Par Value 899 $152.89 $137,452.34
Disclosure

SEC source: 0001739940-26-000047 · wk-form4_1781643916.xml · nonDerivative · entry 1

Kates Jamie G · CIK 0002029677 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 20:16 UTC
Koka Durga PrasadEVP, Global CIO
Tax withholdingCommon Stock, $.01 Par Value 729 $275.53 $200,861.37
Disclosure

SEC source: 0001739940-26-000045 · wk-form4_1780517774.xml · nonDerivative · entry 1

Koka Durga Prasad · CIK 0002086071 · EVP, Global CIO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,552

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
May 29, 2026 Filed Jun 2, 2026 21:13 UTC GrantPhantom Stock Units · Derivative 108.1471 $277.40 $30,000.01
Disclosure

SEC source: 0001586813-26-000004 · wk-form4_1780434804.xml · derivative · entry 1

Kurian George · CIK 0001586813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,922.4494

Underlying: Common Stock, $.01 Par Value · 108.1471 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group's common stock and will be settled in cash.

F2 · ownership.direct: Includes 10.6351 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferral Plan.

Read SEC document
May 13, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,971 $0.00 Strike: $197.35 $0.00
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · derivative · entry 24

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 Par Value · 7,971 shares

Expires 2028-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F17 · shares: This option was granted on February 28, 2018. The option vested in three equal annual installments starting on March 1, 2019.

Read SEC document
May 13, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,458 $0.00 Strike: $149.14 $0.00
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · derivative · entry 22

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $.01 Par Value · 15,458 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F16 · shares: This option was granted on February 28, 2017. The option vested in three equal annual installments starting on March 1, 2018.

Read SEC document
May 13, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionCommon Stock, $.01 Par Value 7,971 $197.35 $1,573,076.85
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 17

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,766

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

Read SEC document
May 13, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionCommon Stock, $.01 Par Value 15,458 $149.14 $2,305,328.83
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 16

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,795

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 85,519 $0.00 Strike: $197.35 $0.00
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · derivative · entry 23

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,971

Underlying: Common Stock, $.01 Par Value · 85,519 shares

Expires 2028-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F17 · shares: This option was granted on February 28, 2018. The option vested in three equal annual installments starting on March 1, 2019.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 103,595 $0.00 Strike: $149.14 $0.00
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · derivative · entry 21

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,458

Underlying: Common Stock, $.01 Par Value · 103,595 shares

Expires 2027-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F16 · shares: This option was granted on February 28, 2017. The option vested in three equal annual installments starting on March 1, 2018.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 2,231 $298.53 $666,026.68
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 15

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,337

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F14 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $298.495 to $298.675 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 15,319 $298.24 $4,568,735.50
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 14

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,568

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F13 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $297.492 to $298.49 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 2,017 $296.84 $598,717.61
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 13

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,887

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F12 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $296.46 to $297.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 34,641 $295.98 $10,253,195.60
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 12

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,904

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F11 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $295.46 to $296.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 38,487 $294.98 $11,352,887.56
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 11

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,545

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F10 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $294.46 to $295.453 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 2,142 $293.92 $629,574.50
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 10

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,032

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F9 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $293.46 to $294.45 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 7,861 $292.88 $2,302,310.81
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 9

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 129,174

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F8 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $292.44 to $293.435 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 12,315 $291.95 $3,595,313.76
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 8

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 137,035

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F7 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $291.44 to $292.435 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 13,732 $291.01 $3,996,088.90
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 7

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 149,350

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F6 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $290.44 to $291.438 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 41,099 $290.00 $11,918,783.98
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 6

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,082

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F5 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $289.435 to $290.43 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 13,839 $288.85 $3,997,456.04
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 5

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 204,181

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F4 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $288.435 to $289.41 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 14,292 $287.96 $4,115,590.06
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 4

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 218,020

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F3 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $287.43 to $288.42 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
SaleCommon Stock, $.01 Par Value 3,903 $286.83 $1,119,505.30
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 3

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 232,312

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2 · price: Represents the weighted average price of the shares sold. The prices actually received ranged from $286.43 to $287.425 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionCommon Stock, $.01 Par Value 85,519 $197.35 $16,877,174.65
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 2

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 236,215

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

Read SEC document
May 12, 2026 Filed May 14, 2026 20:47 UTC
Cordani DavidDirector · Chairman & CEO
Exercise / conversionCommon Stock, $.01 Par Value 103,595 $149.14 $15,449,640.33
Disclosure

SEC source: 0001739940-26-000044 · wk-form4_1778791641.xml · nonDerivative · entry 1

Cordani David · CIK 0001318751 · Director · Chairman & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,696

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:48 UTC
Ozuah PhilipDirector
GrantCommon Stock, $.01 Par Value 782 $0.00 $0.00
Disclosure

SEC source: 0001739940-26-000029 · wk-form4_1777063690.xml · nonDerivative · entry 1

Ozuah Philip · CIK 0001859685 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,583

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:58 UTC
Hathi NeeshaDirector
GrantCommon Stock, $.01 Par Value 782 $0.00 $0.00
Disclosure

SEC source: 0001739940-26-000035 · wk-form4_1777064282.xml · nonDerivative · entry 1

Hathi Neesha · CIK 0001879974 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,151

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:58 UTC GrantCommon Stock, $.01 Par Value 782 $0.00 $0.00
Disclosure

SEC source: 0001739940-26-000036 · wk-form4_1777064329.xml · nonDerivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,891

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:59 UTC
FOSS ERIC JDirector
GrantCommon Stock, $.01 Par Value 782 $0.00 $0.00
Disclosure

SEC source: 0001739940-26-000037 · wk-form4_1777064356.xml · nonDerivative · entry 1

FOSS ERIC J · CIK 0001197007 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,696

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:57 UTC GrantCommon Stock, $.01 Par Value 782 $0.00 $0.00
Disclosure

SEC source: 0001739940-26-000034 · wk-form4_1777064252.xml · nonDerivative · entry 1

ZARCONE DONNA F · CIK 0001243083 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,517

F1 · balance_after: The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 51-52 and 118 of The Cigna Group's proxy statement filed with the SEC on March 13, 2026.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:53 UTC GrantCommon Stock, $.01 Par Value 782 $0.00 $0.00
Disclosure

SEC source: 0001739940-26-000033 · wk-form4_1777064036.xml · nonDerivative · entry 1

MAZZARELLA KATHLEEN M · CIK 0001273233 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,891

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:53 UTC GrantCommon Stock, $.01 Par Value 782 $0.00 $0.00
Disclosure

SEC source: 0001739940-26-000032 · wk-form4_1777063983.xml · nonDerivative · entry 1

Kurian George · CIK 0001586813 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,560

F1 · balance_after: The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 51-52 and 118 of The Cigna Group's proxy statement filed with the SEC on March 13, 2026.

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:51 UTC GrantCommon Stock, $.01 Par Value 782 $0.00 $0.00
Disclosure

SEC source: 0001739940-26-000031 · wk-form4_1777063857.xml · nonDerivative · entry 1

Ross Kimberly A. · CIK 0001536350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,294

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:49 UTC GrantCommon Stock, $.01 Par Value 782 $0.00 $0.00
Disclosure

SEC source: 0001739940-26-000030 · wk-form4_1777063790.xml · nonDerivative · entry 1

Hennigan Michael J · CIK 0001352283 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,350

Read SEC document
April 22, 2026 Filed Apr 24, 2026 20:47 UTC GrantCommon Stock, $.01 Par Value 782 $0.00 $0.00
Disclosure

SEC source: 0001739940-26-000028 · wk-form4_1777063639.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,940

F1 · balance_after: The reporting person's economic interest in The Cigna Group securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of The Cigna Group stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than The Cigna Group stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for The Cigna Group and pages 51-52 and 118 of The Cigna Group's proxy statement filed with the SEC on March 13, 2026.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 00:18 UTC
Neville EverettSee Remarks
SaleCommon Stock, $.01 Par Value 1,719 $288.91 $496,636.29
Disclosure

SEC source: 0001739940-26-000016 · wk-form4_1772583534.xml · nonDerivative · entry 5

Neville Everett · CIK 0001641142 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,670

F5 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.